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1. Introduction 
 
Data-intensive sciences have progressed in modern astronomy [1], 
biology [2-8], computational materials science [9], ecology [10-11] 
and social science [12] because open-access data has increased 
drastically. Data-intensive or -driven discovery in biology requires a 
large open pool of data across the full breadth of the life sciences and 
the access to the pool will invite “New” logic, strategies and tools to 
discover new trends, associations, discontinuities, and exceptions that 
reveal aspects of the underlying biology [2, 5, 6]. Big data biology, 
which is a discipline of data-intensive science, was proposed based on  
  
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
the rapid increasing of omics data produced by genomics, 
transcriptomics, proteomics and metabolomics [2-8].  This situation 
is also a feature of the ethnomedicinal survey and the number of 
medicinal plants is estimated to be 40,000 to 70,000 around the 
world [13] and many countries utilize these plants as blended herbal 
medicines, e.g., China (traditional Chinese medicine), Japan (Kampo 
medicine),  India (Ayruveda, Siddha and Unani) and Indonesia 
(Jamu). Blended herbal medicines as well as single herb medicines 
include a large number of constituent substances which exert effects 
on human physiology through a variety of biological pathways. To 
comprehensively understand the medicinal usage of plants based upon 
traditional and modern knowledge, we add to KNApSAcK Family 
database systems the selected herbal ingredients i.e., the formulas of 
Kampo and Jamu, omics information in plants and humans, and 
physiological activities in humans [14-16]. These information need to 
be connected in a way that enables scientists to make predictions 
based on general principles. 
In this mini-review, we discuss the usage of KNApSAcK Family 
DB in metabolomics, explain mining techniques such as principal 
component analysis (PCA), partial least square regression (PLSR) and 
multiway model, and show their application on Indonesian blended 
herbal medicines (Jamu) as a case study. 
 
2. KNApSAcK Family Database 
 
Omics biology, like most scientific disciplines, is in an era of 
accelerated increase of data, so called big data biology [2-8]. Large-
scale sequencing centers, high-throughput analytical facilities and 
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individual laboratories produce vast amounts of data such as 
nucleotide and protein sequences, gene expression measurements, 
protein and genetic interactions, mass spectra of metabolites and 
phenotype studies. The goal of investigating the interactions between 
medicinal/edible plants and humans is to comprehensively understand 
the molecular mechanism of medicinal plants on human physiology 
based on current and traditional knowledge. Optimization of blended 
herbal formulas should be developing using information derived from 
plant and human omics. To reach this goal we need to develop 
databases based on the platform shown in Fig. 1A. KNApSAcK 
family DBs have been developed for this purpose [14-16]. Relations 
among individual DBs are illustrated in Fig. 1A and main page of 
KNApSAcK Family DB is shown in Fig. 1B. 
 
A 
 
 
B 
 
 
 
 
 
 
 
Four DBs (Lunch Box DB, DietNavi DB, Food Processor DB and 
DietDish DB, a-d in Fig. 1) are about Food & Health related with 
Japanese foods and ingredients explained in Japanese language because 
initially we developed them targeting the Japanese people, but we are 
planning to translate them into English as early as possible. Lunch 
Box DB comprises information on 800 edible species which include 
the species introduced to Japan from outside or originally grown in 
Japan, general information of the crops and the effect of them on 
human health.   
Noncommunicable diseases such as heart disease, metabolic 
disease, cancer and respiratory disease, which superseded the 
infectious diseases because of the development and widespread 
distribution of vaccines and antimicrobial drugs, account for 60% of 
all deaths worldwide and 80% of deaths in low- and middle-income 
countries [17]. Food and ingredients in sanative diet and more 
effective combination of foods beneficial against those 
noncommunicable diseases are accumulated in DietNavi and DietDish 
DBs, respectively (b and d in Fig. 1). FoodProcessor DB comprises 
309 retortable pouch foods encompassed by 261 food ingredients 
produced in Japan, and connected with DietNavi and KNApSAcK 
core by species names of foods. 
To systematize crude drugs by multifaceted view points, we have 
developed four DBs (WorldMap, KAMPO, JAMU and TeaPot DBs 
as shown in e-h of Fig. 1). The KNApSAcK WorldMap DB 
comprises 46,256 geographic zone-plant pair entries in 217 
geographical zones except mini-states such as the Principalities of 
Liechtenstein, Monaco and Andorra, and the Vatican City. 
Prescriptions corresponding to Japanese and Indonesian herbal 
medicines have been accumulated in KAMPO and JAMU DBs, 
respectively. KAMPO DB is comprised of 1,581 primary formulas 
classified in to 336 formula names encompassed by 278 medicinal 
plants which are approved by the National health insurance authority 
in Japan. JAMU DB is comprised of 5,310 formulas encompassed by 
550 medicinal plants and 12 anatomical regions which are approved 
by the National Agency of Drug and Food Control (NA-DFC) of 
Indonesia. Medicinal/edible plants reported in the scientific literature 
have been classified into geographic zones using the International 
Organization for Standardization (ISO3166), which defines 
geographic zones based on the borders between nations and small 
islands. Herbs are defined as any plants with leaves, seeds, and flowers 
used for flavoring, food, medicine, perfume and parts of such a plant 
as used in cooking. Those are accumulated in TeaPot DB. 
Two types of biological activities, that is, activities of natural 
resources and metabolites to other species including human, i.e., 
antibiotic, anticancer and so on are accumulated in Natural Activity 
and Metabolite Activity DBs (Fig. 1B), respectively. The former and 
the latter comprised 33,703 and 6,677 entries, respectively. For 
extension of species-metabolite relationship DB to metabolic 
pathways, it is needed to design secondary metabolic pathway DB for 
detection of metabolic pathways based on enzyme reactions and 
prediction of reactions by peptide sequences. So we have developed 
Motoercycle DB containing 2,421 entries. The metabolomics of 
plants is developing rapidly [18-20 and references in Table 1], and it 
will be an important topic in the systems-biological studies of 
interactions between plants and humans, which is included in the 
topics of big data biology [2-8], with the goal of achieving a holistic 
understanding of plant function and healthcare, including the activity 
of medicinal plants as well as interaction between plants and their 
environment [14-16, 21, 22].  
To facilitate access to metabolite information obtained from 
analytical techniques, we have developed species-metabolite 
relationship DB (KNApSAcK Core DB) which contains 106,418 
species-metabolite relationships encompassing 21,705 species and 
50,897 metabolites. Nine databases of KNApSAcK family (except 
DietDish) are connected with KNApSAcK Core DB to easily obtain 
candidates of secondary metabolites in species utilized in several 
purposes  [23].  The  KNApSAcK  Core  DB   was  utilized   in   very  
Figure 1. Integrated platform of knowledge of medicinal plants and plant 
and human –omics and KNApSacK Family databases. (A) The relations of 
attributes among individual DBs. (B) Main window of KNApSAcK Family 
DB, indexes from a to i in panel A correspond to those in panel B.  
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diverged purposes of metabolomics studies including identification of 
metabolites (‘Exp’ in Table 1), construction of integrated databases 
(‘DB’), bioinformatics and systems biology (‘Bioinfo’) , and cited in at 
least 110 papers listed in Table 1, that is, in 29 papers in the period 
of 2006-2008, 25 papers in the period of 2009, 20 papers in 2010, 
18 papers in 2011, 18 papers in 2012-2013. In addition, it was 
applied in diverged species from bacteria to plants and animals, in 
total 28 species, that is, Angelica acutiloba [74], Arabidopsis lyrata 
ssp. petraea [56], Arabidopsis thaliana[25, 30, 33, 35, 37, 46, 47, 62, 
70, 86, 99, 103, 104, 108, 109, 121, 122], Atriplex halimus [127], 
Bacillus subtilis [113], Brassica oleraceae var capitata [60], Brufelsia 
calycina [81], Capsicum sp. [123], Citrus sinensis [131], Curcuma 
longa [77], Ephedra sp. [67], Escherichia coli [51], Fragaria x 
ananassa [40, 43, 44], Fragaria vesca [105], Glycine max [53], 
Glycyrrhiza uralensis [94], Hordeum vulgare [80, 102], Homo 
sapiens [63, 101], Jatropha curcas [124, 125], Malx x domestica 
[126], Ophiorrhiza pumila [117], Oryza sativa [49, 61], Papaver 
somniferum [42], Rattus norvegicus [39, 97], Rizotania solani [79], 
Solanum lycopersicum [45, 48], Solanum tuberosum [98] and Zea 
mays [120].  
In the period of 2006-2008, many review papers [‘Review’ in 
Table 1] focused on metabolomics platforms integrated by mass-
spectrometry and metabolite databases including KNApSAcK Core 
[29, 31, 34, 38, 42, 49, 52] and on linking chemistry with biology 
[24], and on metabolome researches targeting the model plant 
Arabidopsis thaliana [30, 33, 35, 37]. In 2009, metabolome studies 
were extended to diverged species such as crops and medicinal plants 
[53, 60, 61, 67, 68, 73, 74, 78] and to engineering studies such as 
quality assessment based on metabolomics [73, 74]. Thus 
metabolomics was applied from model species to crops and medicinal 
herbs. In the period of 2010-2013, metabolomics was further 
extended to genetics such as QTL [80, 98, 126], and to explanation 
of species by metabolites, i.e., ecological subjects [85] phytoalexins 
[119], herbivore-induced metabolites [120] and defense against 
pathogens [131], and to stress responses [115, 116, 127]. In addition, 
metabolomics has also been tried in imaging studies [112, 129]. 
Species-metabolite relation database KNApSAcK Core has been 
utilized in the extended fields of metabolomics researches and the 
horizon of metabolomics researches could be recognized by reviewing 
the works that utilized and/or cited the KNApSAcK DB.  
Methodologies for multivariate analysis to statistically process the 
massive amount of metabolome data were reviewed in [16] and to 
systematize blended herbal medicines in Kampo [15]. In the following 
section, we focus on the mining studies of blended herbal medicines 
for systematically understanding the composition of medicinal herbs 
to efficacies on humans, that is, principal component analysis (PCA) 
that makes it possible to systematize the ingredient in individual 
blending systems, partial least squares (PLS) that can relate the 
ingredients of medicinal herbs to the efficacies and N-PLS that can 
connect multi-factors to the efficacies. We initially explain individual 
techniques in Section 3 and then discuss their application in data-
mining of blended types of herbal medicines in Section 4.  
 
3. Mathematical Methods of Data Mining 
 
PCA is a linear transformation of a large number of interrelated 
variables into a new set of variables, called as the principal 
components (PCs), which are uncorrelated and ordered so that the 
first few retain most of the variation present in all the original 
variables [132]. 
Consider a data matrix A = (a1 a2 … ap) with n observations and 
let V (p x p) be the variance-covariance matrix of A.  The principal 
components of A, Z = (z1 z2 … zp), are calculated as 
 
zj = Acj    ( j = 1, 2, …, p)                                                              
 
where cj is the j-th eigenvector of V which correspond to the j-th 
eigenvalue of V (j).  The properties of PCs are: (1) Var(zj) = j; (2) 
Cov(zj,zj’) = 0, j  j’; (3) Var(z1)  Var(z2)  … Var(zp).  The 
cumulative proportion of variance of the original variables explained 
by the first J principal components can be obtained as 
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PLSR is a regression method, which assumes underlying factors 
among the predictors account for most of the response variation [133, 
134].  These underlying factors of X-variate 
 
T = XW                                                                                          
 
are obtained by maximizing their covariance with the corresponding 
underlying factors of Y-variate where X is an n  m matrix of 
predictors, Y is an n  p matrix of responses, T is an n  c matrix of 
X-score factors, and W is m  c matrix of weight.  Note that n is the 
number of observations, m is the number of predictors, p is the 
number of responses, and c is the number of components.   
The X-score factors, i.e. matrix T, have the following 
properties [133]. 
 
a. When multiplied by loadings P, they are good summaries of X, 
i.e. the X-residuals E are small 
 
X = TPt + E                                                                                 
 
b. The X-score factors are good predictors of Y, i.e. 
 
Y = TQt + F                                                                                 
 
The Y-residuals F express the deviations between the observed and 
modeled responses. 
Based on Eq. (3), Eq. (5) can be rewritten as a multiple regression 
model 
 
Y = XWQt + F = XB + F                                                             
 
Thus, PLSR coefficients B can be written as  
 
B = WQt                                                                                     
 
whereas prediction of the responses can be obtained from 
 
t
XWQY ˆ                                                                                 
 
Although PLSR is not specifically designed to discriminate 
among groups, Barker and Rayens [135] have demonstrated that 
PLSR can be used for such purposes by connecting PLSR and Linear 
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Discriminant Analysis (LDA); this combined method is called as 
Partial Least Square Discriminant Analysis (PLS-DA).  In PLS-DA, 
group membership is transformed into a dummy matrix, and this 
dummy matrix provides the response variables for PLSR.   
 
 
 
 
 
 
An extension of PLSR to deal with multidimensional data known 
as Multiway Partial Least Squares has been developed by Bro [136] 
and is called as N-PLS. In this model, the same principle of PLSR for 
two dimensional data is utilized, that is, both predictor and response 
blocks are decomposed successively into multi-linear model such that 
the pairwise scores have maximal covariance. The score of the 
predictor is then regressed to the response variable. Fig. 2 illustrates 
the decomposition of N-PLS model. Moreover, N-PLS model can 
also be used for discrimination purpose, which is called as N-PLS-
DA, that is the multiway version of PLS-DA, by utilizing the dummy 
matrix of group membership as the response variable.  
Consider the three-dimensional array X indexed by observation (i 
= 1, 2, …, I), type I variable (j = 1, 2, …, J) and type II variable (k 
= 1, 2, …, K). The decomposition of both the predictor and the 
response block based on N-PLS model are as follows 
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The array X is decomposed into a tri-linear model consisting of 
one score vector for observation called tc (I x 1), and two weight 
vectors, one for type I variable called 
J
cw   (J x 1) and one for type II 
variable called 
K
cw  (K x 1). Similarly, a bi-linear model is used in 
decomposing the matrix Y into one score vector vc (I x 1) and one 
weight vector uc (L x 1). The decomposition is conducted such that 
the covariance among the score of predictor t and the corresponding 
score of the response v is maximized. All scores and weights are 
indexed with c showing that they correspond to cth multiway 
component, while C represents the total number of multiway 
components used in N-PLS model. Moreover, E and F are the 
residuals of the decomposition of the three-dimensional array X and 
matrix Y, respectively. 
 
 
 
 
 
 
 
 
Furthermore, let Xk (I x J) be the kth slice of X (I x J x K) for the 
corresponding kth of type II variable, then matricizing three-
dimensional array X into matrix X (I x JK) is performed as follows 
[137] 
 
X = [X1 | X2 | … | XK]                                                                
 
Fig. 3 depicts this unfolding process of array X into matrix X. 
Using this notation, the score tc of the cth component can be 
calculated as [138] 
 
)( Jc
K
cct wwX    
or 
Figure 2. Schematic diagram of the decomposition of both predictor and 
response blocks for: (a) PLS and (b) N-PLS model. 
 
Figure 3. Illustration of matricizing three-dimensional array X (I x J x K) into 
matrix X (I x JK). 
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From Eq. (12), the weight corresponding to cth component, wc 
(JK x 1), can be defined as 
 
)( Jc
K
cc www                                                             
Smilde [140] also described that, due to the deflation in X during 
the decomposition, the weight matrix W (JK x C) can be applied 
directly to the original unfolded matrix X is defined as 
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Hence, the scores in T (I x C) expressed directly in terms of the X-
columns is 
 
T = XW                                                                                    
 
After the decomposition procedure, the next step is to regress Y on 
the component scores T 
 
TBY ˆ                                                                                     
 
with 
 
B = (TtT)-1TtY                                                                      
 
From Eq. (15) and (16) we have 
 
XWBYˆ                                                                                  
 
Therefore, the regression coefficients BNPLS (JK x L) needed to predict 
Y from X are obtained as 
 
BNPLS = WB                                                                               
 
4. Illustration of Data Mining Techniques 
 
Indonesia, the mega-biodiversity center like Brazil, has at least 
9,600 species of plants with pharmacological activity [110] and has 
developed blended herbal medicines called Jamu taking modern and 
traditional knowledge of herbs into consideration. To prepare Jamu, 
several plants are selected and mixed such that the concoction has the 
desired efficacy. Traditionally, plants are chosen based on prior 
experience which is passed down from generation to generation. In 
curing a particular disease, each ethnic group in Indonesia may have 
its own formulas, whose specific nature depends strongly on the local 
plant resources in the region where a given population lives and the 
efficacies of Jamu medicines have been empirically demonstrated 
[139-142]. Data mining techniques with the blended herbal medicine 
databases such as KAMPO and JAMU (Fig. 1) makes it possible to 
comprehensively and mathematically understand those blended herbal 
systems. Fig. 4 illustrates a network connecting efficacy, herbal 
medicine, plant, and pharmacological activity of plant. The network 
showing that crude medicines M1, which is useful for efficacy E1, use 
three plants in its ingredients: plant P1, P3, and P4.  Plant P1 has two 
pharmacological activities: A2 and A4.  Plant P2 also has two 
pharmacological activities: A1 and A2, while plant P3 has three 
activities: A3, A4, and AK.  The other connections can be described 
similarly.   
From the concept of integrated platform of knowledge of 
medicinal plants and plant and human-omics depicted in Fig. 1, the 
efficacy layer in Fig. 4 represents the physiological activity layer in 
human-omics attribute, the herbal medicine and plant layer represent 
the prescription and medicinal herb layer, respectively, in knowledge 
of medicinal plants attribute, while the pharmacological activity layer 
represents the metabolomics layer in plant-omics attribute. On the 
following section we will illustrate the data mining techniques on 
herbal medicine database analyzing relationship among entities for 
two, and more than two attributes. 
 
 
 
 
 
 
As an illustration for data mining of herbal medicine database 
which rely on relationship between two attributes, the relationship 
between the efficacy of Jamu and medicinal plants used in Jamu is 
explored using PCA [143-145]. The efficacies of 3,138 Jamu are 
classified into one of nine categories, namely: (1) disorders of appetite 
(DOA), (2) disorders of mood and behavior (DMB), (3) female 
reproductive organ problems (FML), (4) gastrointestinal disorders 
(GST), (5) musculoskeletal and connective tissue disorders (MSC), 
(6) pain/inflammation (PIN), (7) respiratory disease (RSP), (8) 
urinary related problems (URI), and (9) wounds and skin infections 
(WND). In total, those 3,138 Jamu use 465 plants in their 
ingredients.  The distribution of Jamu and plant utilized in Jamu for 
each efficacy is shown in Table 2. 
Note that, one plant may be used in many Jamu with varying 
efficacies. Hence, it is interesting to find out the most significant 
effects of specific plants by analyzing their usage in Jamu, and 
considering that the more useful a given plant in having certain effect, 
the more frequently the plant will be used in Jamu when that effect is 
desired.  Biplot, a multivariate exploration tool, is suitable for this 
purpose because it provides simultaneous plot of principal component 
scores and loadings, as representation of observations and variables, 
respectively [145]. Considering plants as observations and efficacy 
groups as variables, the relationship between them can be explored 
using a biplot. 
Figure 4. A typical network illustrating connections between efficacy, 
herbal medicine, plant, and pharmacological activity of plant. 
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Following the explanation of PCA in previous section, the data 
matrix A as an input for PCA is generated by putting plant as 
observation and efficacy as variables. So, A consists of 465 rows and 9 
columns.  Each cell aij shows the number of Jamu that use plant i and 
useful for efficacy j. 
 
 
 
 
 
 
 
Biplot configuration using the first two components is shown in 
Fig. 5. In the figure, plants are represented as red points while Jamu 
efficacies as blue lines, i.e. vectors based on loadings. The length of a 
given efficacy line showing the variability of plant usage for the 
corresponding efficacy, that is, the longer the efficacy line the larger 
the variability of plant usage for that efficacy. From Fig. 6, it is 
obvious that efficacy MSC has the largest variability of plant usage, 
followed by efficacy GST and FML. On the other hand, efficacy 
DMB has the smallest variability of plant usage, followed by efficacy 
URI and RSP. This finding can be addressed due to two factors, that 
is, the number of Jamu as well as the number of plant utilized in the 
corresponding efficacy (see Table 2). Efficacies with large variability 
of plants usage (MSC, GST, and FML) have large values for both 
factors; in contrast, efficacies with small variability of plants usage 
(efficacy DMB, URI, and RSP) have small values for both factors. 
In the configurations, many plants are clustered in the center. 
Note that, the projection value of plants' point on a given efficacy line 
is the prediction of the frequency of plants usage on that efficacy. So, 
these clustered plants are basically plants whose frequencies of usage 
in Jamu are very low. In contrast to the clustered plants, some plants 
are spread out and located near the efficacy for which the plants are 
highly utilized. For example, Ginger (Zingiber officinale) is located 
near the efficacy MSC. Ginger is well known for its function of 
refreshing body, and for this reason many Jamu use Ginger for 
efficacy MSC which can easily be identified from biplot 
configuration. Another example is Turmeric (Curcuma longa) which 
located near the efficacy FML. Due to its analgesic and antimicrobial 
activity, this plant is well known and highly utilized in Indonesia as 
ingredient of Jamu formula for women during menstruation, which is 
a problem that classified into efficacy FML. Thus, the biplot 
configuration exhibits useful information in exploring the relationship 
between plants and the efficacy of Jamu. 
Another illustration for relationship between two attributes on 
data mining of herbal medicine database is the modeling of Jamu 
ingredients (representation of knowledge of medicinal plants) to 
predict the efficacy (representation of human omics). This analysis is 
performed because of the fact that Jamu is prepared from a mixture of 
several plants. The plants are chosen so that the Jamu has the desired 
efficacy. As a result, the composition of the plants used in Jamu 
formula determines the efficacy. Thus, it is interesting to model the 
ingredients of Jamu, i.e. the constituent plants, and use this model to 
predict efficacy. PLS-DA, a statistical model for classification and 
discrimination based on Partial Least Square Regression (PLSR), is 
suitable for this analysis because a large number of plants are used in 
Jamu, whereas Jamu efficacies can be grouped into a few categories or 
classes. In this method, the plants used in each Jamu medicine served 
as the predictors, whereas the efficacy of each Jamu provided the 
responses. 
The data structure used for PLS-DA is as follows. The data 
matrix X in X-block contains plant usage status. The dimension of 
matrix X is (I x J), where I is the number of Jamu (in this case, 
3,138), and J is the number of plants (in this case, 465). Because of 
the availability of information about Jamu products, which generally 
do not state in detail the mixing ratio of the plants used, the 
predictors X is constructed only in binary data. Each cell xij (i = 1, 2, 
…, I; j = 1, 2, …, J) is set to 1 if Jamu i uses plant j, and is set to 0 
otherwise. In the present study, nine indicator variables, which 
correspond to the 9 efficacies listed in Table 2 perform as the Y-
block in PLS-DA modeling. Thus, the dimension of data matrix Y is 
(I x 9). Each cell yil (l = 1, 2, …, 9) is set to 1 if Jamu i is classified 
into efficacy group l, and is set to 0 otherwise. Note that 
  
9
1
1
l il
y  because each Jamu is classified to one efficacy only. 
Using the derived PLS-DA model, we can then use it to predict 
the efficacy of Jamu given information of the ingredients. In this 
analysis, among the 3,138 Jamu medicines, the efficacies of 2,248 
Jamu medicines (71.6%) can be assigned to an individual efficacy 
reported. Hence, the efficacy in most Jamu medicines can be predicted 
on the basis of medicinal plants used. The percentages of correct 
prediction for each efficacy (see Table 3) vary from 22.7% for 
efficacy DMB to 89.8% for efficacy GST. The low percentage of 
correct prediction for efficacy DMB can be addressed due to the small 
number of Jamu for this efficacy, which is only 22 out of 3,138 Jamu 
(see Table 2). 
Figure 5. Biplot configuration based on PCA analysis of Jamu data. Plants 
and Jamu efficacies are represented as red points and blue lines, 
respectively. 
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Furthermore, plants in the ingredients of Jamu are used as main 
ingredients, which contribute primarily to the medicines' efficacies; 
other plants are used as supporting ingredients [146, 147]. 
Investigating which plants are main ingredients and which are 
supporting is important in order to comprehensively understand the 
mechanisms by which specific plants achieve desired efficacies.  The 
regression coefficients of previous PLS-DA model, which relates 
plants usage in Jamu as predictors and Jamu efficacy as response, can 
be helpful in this attempt because they summarize the effect of plant 
on efficacy. Plants that act as main ingredients will have significant 
effect on the model developed.  Furthermore, due to the absence of 
parametric testing for the PLS-DA coefficients, the evaluation for 
significance is performed using permutation testing, in which the 
distribution of coefficients under the null hypothesis is generated via 
resampling of the existing data [149]. 
 
 
 
 
 
 
 
 
 
The resampling is performed by permuting the order of the 
responses (in this case, Jamu efficacies) while maintaining the order of 
the predictors (in this case, plant utilization as Jamu ingredients) so 
that the existing relationship between the predictors and the response 
is destroyed and a new data set is generated under the null hypothesis, 
i.e., plant utilization in Jamu does not affect Jamu efficacy. If we 
perform such resampling many times and apply the PLS-DA model 
on the new data generated from the resampling, the accumulation of 
the PLS-DA coefficients obtained from this process generates a 
distribution, against which a p-value can be calculated and 
subsequently evaluated for significance [150]. 
The results of the significance testing of all plants used in each 9 
efficacies are shown in Table 4.  Note that one plant may be used for 
more than one efficacy. From the testing, we observed 234 plants 
(50.3% among all 465 plants) showing no significant status for all 9 
efficacies; whereas the other 231 plants have significant status which 
comprise of 189 plants (40.6%) are significant only for 1 efficacy, 38 
plants (8.2%) are significant for 2 efficacies, and the other 4 plants 
(0.9%) are significant for 3 efficacies.  Besides testing the plants usage 
statistically, furthermore, we also checked from scientific papers the 
usage of significant plants in their corresponding efficacy. Many of 
the results we obtained by our analysis are supported by scientific 
papers. 
Note that in predicting Jamu efficacy based on the information of 
its ingredients we can also use other methods such as discrimination 
analysis, nominal logistic regression, and support vector machine. 
However, in the present study we focus on PLS-DA in classifying 
Jamu efficacy by taking into consideration that we also intend to 
evaluate the significance of plant usage in Jamu to achieve specific 
efficacy as well as extending the analysis into three-way model by 
adding the plant pharmacological activity into predictors’ block.  
 
Figure 6. Clustergram of pharmacological activity against Jamu efficacy.  
The red and black cells indicate that the pharmacological activity is 
significant or non-significant, respectively, to the corresponding efficacy. 
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During the modeling process of PLS-DA in the previous section, 
the ingredients of Jamu provide the predictor while the Jamu efficacy 
serves as the response. In order to identify the function of the plants 
in Jamu to achieve specific efficacy, the reported pharmacological 
activities of the plants are added to the predictors block. Thus, the 
predictors block can be represented as a three-dimensional array X (I 
x J x K) indexed by Jamu medicine (i), plant (j), and pharmacological 
activity (k) as depicted in Fig. 2 with Jamu medicine, plant, and 
pharmacological activity serve as observation, type I and type II 
variables, respectively. Furthermore, the response block is represented 
as matrix Y (I x 9).  This analysis then connects three attributes: (1) 
knowledge of medicinal plants (represented by Jamu and plants 
corresponding to JAMU DB in Fig 1); (2) plant omics (represented 
by pharmacological activity corresponding to Biological activity (Nat) 
in Fig 1); and (3) human omics (represented by efficacy). 
The detail about the elements of array X and matrix Y is as the 
following. Let xijk (k = 1, 2, …, K; K = 46 where K is the number of 
reported pharmacological activity; see previous section on definition 
of i, j, I, and J) denotes the usage status of plant j with 
pharmacological activity k in Jamu i, where xijk = 1 if the plant j with 
pharmacological activity k is used in Jamu i, and xijk = 0 otherwise. 
On the other hand, let yil represents the status of Jamu i on efficacy l, 
where yil = 1 if Jamu i is classified into efficacy l, and yil = 0 
otherwise.  
In order to identify the pharmacological activity that is 
significantly related with the efficacy, we adopt the guidelines from 
Hair et al. [150] that all weights wK (in absolute values) of 0.3 or 
above are significant for sample sizes of 350 or greater.  Figure 6 
depicts the 2-dimensional dendrogram of Jamu efficacy and the 
pharmacological activity significantly related with the efficacy. The 
cluster of Jamu efficacy and the pharmacological activity was 
performed using Ward Linkage based on the Euclidean distance 
among the entities. The clustering of the pharmacological activity side 
clearly exhibits two groups. The first group consists of activities 
useful for one or two efficacies only. This group can be regarded as a 
group of specific activity because the effects of the activities are 
specific for certain efficacy. For example the diuretic activity is useful 
for efficacy URI and DOA. Diuretic is an agent that increases the 
secretion and elimination of urine from the body [151]. Obviously, 
this activity is beneficial for the efficacy URI.  Diuretic also help the 
body eliminate waste and support the whole process of inner 
cleansing, which is an action that is useful for efficacy DOA especially 
related with a slimming purpose. The five activities 
(antihaemorrhoidal, carminative, hypoglycaemic, depurative, and 
anthelmintic) are specifically related with efficacy GST. 
Antihaemorrhoidal means an activity that treats haemorrhoids (piles), 
while the carminative is defined as an activity that eases discomfort 
caused by flatulence. Hypoglycaemic activity helps reduce the levels of 
sugar in the blood, whereas the depurative eliminates toxins and 
purifies the system especially the blood, and the anthelmintic helpful 
in expelling parasites from the gut. Thus, all of these activities are 
helpful for the problem related with the digestive system, i.e. the 
efficacy GST. 
Furthermore, the second group of activity revealed by the 
dendrogram consists of activities useful for at least four efficacies. In 
contrast to the first group, this group can be regarded as the general 
activities because of the diverse efficacies related to this group. Among 
all activities clustered to this group, antimicrobial activity is 
significantly related with all 8 efficacies. We can interpret this result 
as follows. Due to the environmental conditions, hygiene, and its 
location as a tropical country which led to many microbes that are 
harmful to health, then it is reasonable that antimicrobial activity is 
important and should be available in many Jamu formulas in 
Indonesia. It should be noted that many popular medicinal plants in 
Indonesia such as Temulawak (Curcuma xanthorriza), Ginger 
(Zingiber officinale), Turmeric (Curcuma longa) or Kencur 
(Kaempferia galanga) have content of this activity [152]. 
Anti-inflammation, antispasmodic, analgesic, sedative, and 
stimulant are also clustered into this general activity group. Since 
many health problems or diseases are often accompanied with 
inflammation or spasm, then the plants with anti-inflammation 
and/or antispasmodic activity are chosen in many Jamu formulas. 
Those health problems/diseases often cause pain or other 
discomforts, thus plants with certain activities such as analgesic or 
sedative effects are chosen in many Jamu medicines. Finally, stimulant 
activity, which excites or quickens activity of the physiological 
processes, is important for the recovery reason after one experiencing 
those health problems or diseases. 
From the previous explanation regarding the grouping of 
pharmacological activity, it can be concluded that in formulating Jamu 
the plants are selected so that, beside curing the targeted diseases or 
health problems as indicated by the specific activities, the plants also 
should overcome the other discomforts caused by the targeted diseases 
or health problems as indicated by the general activities. It is in 
accordance with the process of making the Jamu medicines that 
involving whole part of plant and not only the specific active 
components. Hence specific or general pharmacological activities of 
components are involved during the curing process of Jamu medicines 
towards targeted diseases or health problems. 
 
 
5. Concluding Remarks 
 
Biology, like most scientific disciplines, is in an era of accelerated 
information gathering and scientists increasingly depend on the 
availability of amounts of data such as nucleotide and protein 
sequences, protein and gene expression, dynamics of metabolites etc. 
The nature of current systematic understanding of big data biology 
towards health, nutrition, and other societal issues have recently 
become the focus of scholar in societal studies of science and 
information studies. The rise of community databases, i.e., 
KNApSAcK family DB introduced in the present review, has been 
strongly associated with the current emphasis on data-intensive 
science. The central question is whether scientists can deduce how 
systems and whole organisms work from this torrent of molecular 
data. To progress this situation, data-intensive approach is needed for 
understanding intra- and inter-relations in individual layers 
represented in Fig. 1. The former can be solved based on a type of 
multivariate analyses such as cluster analysis and principal component 
analysis. Though the latter is more complicated, several approaches 
including PLS and N-PLS make it possible to clarify and understand 
those relations. The big data biology has become an inevitable part of 
biology, and the laws of nature could be clarified based on global 
analysis of big data biology the era of which has appeared. For 
centuries biological research mainly depended on experiments and for 
a decade or two computational analysis has usually followed 
experimentation but future it might be the opposite i.e., 
computational analysis is done first to guide the experimental design 
facilitated by versatile and freely available omics data at various 
databases. 
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